HEALTHNY POST
Ozempic nation: America’s GLP-1 use nearly quadruples in just two years
America's use of GLP-1 medications, such as Ozempic, has nearly quadrupled in two years, contributing to a national trend of weight loss through injection-based treatments.
Related Signal
Adjacent reporting
- GLP-1 insurance change impacts millions of Americans: What to know, how to tell if you’re covered
- GLP-1 use reaches new high in US
- GLP-1 insurance change impacts millions of Americans: What to know, how to tell if you're covered
- Doctors reveal hidden danger for some Ozempic, Wegovy users with brain disorders